E.g. HCV, STIs
-+*Download pdf Questions Key take-home messages The issue and why it’s important Globally, the population of people living with HIV is aging. For example, according to 2022 data from the Centers for Disease Control and Prevention, approximately 54% of people living with HIV in the U.S. were 50 years and older (16). HIV surveillance data […]
Cancer in older adults living with HIV Read More »
-+*Download pdf Questions Key take-home messages The issue and why it’s important Sexually transmitted infections (STIs) are rising globally: more than one million new infections of syphilis (caused by bacteria Treponema pallidum), gonorrhea (bacteria Neisseria gonorrhoeae), chlamydia (bacteria Chlamydia trachomatis), and trichomoniasis (protozoan Trichomonas vaginalis) occur each day worldwide (29). In Canada (1) and the
-+*Download pdf Questions Key take-home messages The issue and why it’s important In Canada, bacterial STIs are a significant public health concern as incidence rates have risen markedly since 2010 (21). Between 2010 and 2019, the number of reported cases of chlamydia, syphilis, and gonorrhea all increased, by 33.1%, 393.1%, and 181.7%, respectively (21). One
-+*Download pdf Question Key take-home messages The issue and why it’s important Hepatitis C virus (HCV) is transmitted when the blood of an infected person comes into contact with the blood of an uninfected person (23). Approximately 25% of individuals spontaneously clear the virus after infection; however, the majority of individuals go on to develop
-+*Download pdf What are the best practices of cost-effective testing for HIV and bacterial STIs (chlamydia, gonorrhea, syphilis and trichomoniasis)? Key take-home messages Rates of chlamydia, gonorrhea, and infectious syphilis have risen in Canada from 2015 to 2019 (1). An observed decrease in HIV cases has been detected recently, however a reduction in testing services
Cost-effective strategies of testing for HIV and sexually transmitted infections (STIs) Read More »
-+*Download pdf Questions What are best practices to increase the uptake of HIV and HCV testing among people who use drugs? Key take-home messages Interventions that provide HIV and/or HCV testing have been offered in a variety of settings. These include community settings such as outpatient drug treatment clinics (1–5), mobile clinics (6), harm reduction
Best practices to increase the uptake of HIV and HCV testing among people who use drugs Read More »
-+*Download pdf Questions What are the examples of providing internet-based HIV/STI testing services in high-income settings (both publicly and privately funded)? What is the uptake of such services and which population groups benefit from them? What are the implications of these services for access, standard of practice, quality of care, and costs? Key take-home messages
-+*Download pdf Questions What are the effective interventions and best practices to reduce syphilis transmission among various population groups? Key take-home messages Infectious and congenital syphilis rates have seen a sharp growth in Canada since 2016 (1). The COVID-19 pandemic impact on syphilis rates is undetermined: some studies have shown that there are observed decreases
Interventions and best practices to address increasing rates of syphilis transmission Read More »
-+*Download pdf Question What is the effectiveness of and what are the best practices for using contingency management and incentives for health care issues such as HIV, STIs, and PrEP? Key take-home messages Using contingency management and incentives at the different steps of HIV care continuum (such as testing, treatment adherence, viral suppressions) is widely
-+*Download pdf Questions What is the effectiveness of and what are the best practices for using contingency management and incentives to support linkage to care and treatment for hepatitis C infection among people who use drugs? Key take-home messages Recent studies in Canada have indicated that hepatitis C virus (HCV) treatment uptake among individuals who
